A Phase 1b Randomized, Double-blind, Placebo-Controlled, Experimental Medicine Study of Fosigotifator in Adults With Major Depressive Disorder
Latest Information Update: 03 Nov 2024
At a glance
- Drugs Fosigotifator (Primary)
- Indications Major depressive disorder
- Focus Adverse reactions
- Sponsors AbbVie
- 26 Oct 2024 Status changed from not yet recruiting to recruiting.
- 04 Oct 2024 New trial record